BPC-157
Product
An experimental peptide studied primarily in preclinical research for tissue repair, inflammation, and angiogenesis; it is not an FDA-approved general medical treatment.
4 episodes featuring BPC-157
The Dylan Gemelli Podcast
Josh Axe links recovery to personalized cellular health
The conversation examines how rehabilitation, foundational habits, faith, and targeted testing can shape an individualized approach to recovery and longevity.
Sep 12, 2026 · 1h 21m
The Dylan Gemelli Podcast
MOTS-C Promises Metabolic Gains, But Evidence Remains Early
The episode examines whether MOTS-C can meaningfully improve metabolism, performance, recovery, and healthy aging while its safety profile remains under study.
Sep 1, 2026 · 12 min
unPAUSED with Dr. Mary Claire Haver
Testosterone enters the menopause conversation
The episode examines what women’s testosterone may do, where evidence remains thin, and how dosing and monitoring shape treatment risk.
Sep 1, 2026 · 1h 13m
The Shawn Ryan Show
Koniver challenges medicine’s shortcuts with personalized longevity care
The conversation tests where individualized health optimization can offer useful alternatives—and where emerging therapies remain uncertain, experimental, or overpromoted.
Aug 13, 2026 · 2h 20m